A practical reference on mass spectrometry: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-10-26. Anything still debated is marked as such rather than presented as settled.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
| Property | Value | Notes |
|---|---|---|
| Name type | Commercial trade name | Not a systematic chemical identifier |
| Parent peptide | Thymosin beta-4 | 43-residue natural peptide |
| Common fragment sequence | LKKTETQ | Maps to part of the actin-binding region |
| Molecular size class | Roughly 0.8-1.0 kDa | Depends on exact fragment and terminal modification |
| Regulatory status | Prohibited in sport | Grouped with peptide hormones in many frameworks |
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
==== Drug discovery ==== Quantitative proteomics has the largest applications in the protein target identification, protein target validation, and toxicity profiling of drug discovery. Drug discovery has been used to investigate protein-protein interaction and, more recently, drug-small molecule interactions, a field of study called chemoproteomics. Thus, it has shown great promise in monitoring side-effects of small drug-like molecules and understanding the efficacy and therapeutic effect of one drug target over another. One of the more typical methodologies for absolute protein quantification in drug discovery is the use of LC-MS/MS with multiple reaction monitoring (MRM). The mass spectrometry is typically done by a triple quadrupole MS.
With osemozotan administration, the number of marbles buried was decreased with apparently little to no loss in motor coordination; these test results support the theory that osemozotan may be useful in the treatment of OCD. It has been noted that sensitization to cocaine may stem from action of the 5-HT1A receptor. While the role of 5-HT receptors with methamphetamine is still not certain, the use of osemozotan was found to decrease 5-HT levels in patients on repeated methamphetamine exposure; this may be a possibility for treatment of drug dependence with cocaine and methamphetamine.
=== High population densities === Since sea ice pockets are confined and highly-concentrated ecosystems, they are able to house several orders of magnitude greater population densities of bacteria and protists than are found in the open ocean (up to thousands of individuals per liter for protists). This high abundance of organisms can pose challenges, as different bacteria and protists will compete for resources. A high density of microorganisms can result in the accumulation of metabolic byproducts, such as oxygen, dissolved organic matter, ammonia, and dimethylsulfoniopropionate (DMSP). Some organisms can gain a selective advantage within brine pockets as the high population density can result in increased rates of horizontal gene transfer because organisms are in close proximity. Horizontal gene transfer can allow certain organisms to obtain genes from bacteria that may be advantageous in a light-limited, extremely cold environment.
=== Supercritical water electrolysis === Electrolysis of water in a supercritical state reduces the overpotentials found in other electrolysers, thereby improving the electrical efficiency of the production of oxygen and hydrogen. Increased temperature reduces thermodynamic barriers and increases kinetics. No bubbles of oxygen or hydrogen are formed on the electrodes, therefore no insulating layer is formed between catalyst and water, reducing the ohmic losses. The gas-like properties provide rapid mass transfer.
Filament notching is due to uneven evaporation of the filament. Small variations in resistivity along the filament cause "hot spots" to form at points of higher resistivity; a variation of diameter of only 1% will cause a 25% reduction in service life. Since filament resistance is highly temperature-dependent, spots with higher temperature will have higher resistance, causing them to dissipate more energy, making them hotter – a positive feedback loop. These hot spots evaporate faster than the rest of the filament, permanently increasing the resistance at that point. The process ends in the familiar tiny gap in an otherwise healthy-looking filament. Lamps operated on direct current develop random stairstep irregularities on the filament surface which may cut lifespan in half compared to AC operation; different alloys of tungsten and rhenium can be used to counteract the effect. Since a filament breaking in a gas-filled bulb can form an electric arc, which may spread between the terminals and draw very heavy current, intentionally thin lead-in wires or more elaborate protection devices are therefore often used as fuses built into the light bulb. More nitrogen is used in higher-voltage lamps to reduce the possibility of arcing.
Sources: en.wikipedia.org
in his eagerness to weaken it, has cut off all possibility of understanding between the two Masonic Bodies existing and recognized in the Republic of Cuba." They also stated that since the signing of the Treaty of Friendship and Mutual Recognition in 1876, whenever a sanction was issued by the Supreme Council, that the Grand Lodge would show solidarity in issuing the same sanction. If Urquía Carreño did not step down, it would not only be a violation of Masonic Law, but also break almost a century and a half of tradition. If the Treaty of Friendship broke down, they said, it would only be an invitation for the State Security Unit to further infiltrate the brotherhood. Urquía Carreño still refused to step down. After this, certain Lodge Masters sent letters to the United States government, requesting that if Urquía Carreño tried to claim asylum there, to deny him this right for his alleged involvement and collaboration with the State Security Unit.
==== Specialty selection ==== The Swedish medical specialty system is, as of 2015, made up of three different types of specialties; base specialties, subspecialties, and add-on specialties. Every physician wishing to specialize starts by training in a base specialty and can thereafter go on to train in a subspecialty specific to their base specialty. Add-on specialties also require previous training in a base specialty or subspecialty but are less specific in that they, unlike subspecialties, can be entered into through several different previous specialties. Furthermore, the base specialties are grouped into eight classes—pediatric specialties, imaging and functional medicine specialties, independent base specialties, internal medicine specialties, surgical specialties, laboratory specialties, neurological specialties, and psychiatric specialties. It is a requirement that all base specialty training programs are at least five years in length. Common reasons for base specialty training taking longer than five years is paternity or maternity leave or simultaneous Ph.D. studies.
== Redox-Neutral Radical Cross-Coupling == In 2025, the Baran laboratory reported a general platform for "redox-neutral radical cross-coupling" employing sulfonyl hydrazides as stable, crystalline radical precursors. These reagents, prepared from a variety of feedstocks (including alcohols, carbonyl compounds, amines, and hydrazines), function as dual-purpose agents: they generate alkyl radicals while donating electrons to activate the nickel catalyst. This eliminates the need for external redox additives, photoredox catalysts, electrochemical setups, or pyrophoric organometallic reagents. The reactions operate under Suzuki-like conditions—an inexpensive nickel catalyst, mild base, and gentle heating—with nitrogen gas as the sole byproduct. The platform enables C–C bond-forming transformations with multiple partner classes, including activated olefins (Giese-type additions), alkyl halides, redox-active esters, (hetero)aryl halides, alkenyl halides, alkynyl halides, and trifluoromethylating reagents. These couplings forge C(sp³)–C(sp³), C(sp³)–C(sp²), and C(sp³)–C(sp) bonds and have been adopted in medicinal chemistry programs for the rapid assembly of complex, sp³-rich scaffolds and fragment libraries. Later in 2025, the same sulfonyl hydrazide platform was extended to achieve stereospecific (stereoretentive) radical cross-couplings. Using readily accessible enantioenriched sulfonyl hydrazides and an achiral nickel catalyst, the method delivers high levels of stereoretention through an inner-sphere mechanism.
In the United States it was the best-selling medication between 1968 and 1982, selling more than 2 billion tablets in 1978 alone. In 2023, it was the 183rd most commonly prescribed medication in the United States, with more than 2 million prescriptions. In 1985 the patent expired, and there are more than 500 brands available on the market. It is on the World Health Organization's List of Essential Medicines.
In 2007, the WHO stopped recommending BCG for infants with HIV, even if the risk of exposure to tuberculosis is high, because of the risk of disseminated BCG infection (which is roughly 400 per 100,000 in that higher risk context).
Sources: en.wikipedia.org
With the announcement of GPT-2 in 2019, OpenAI originally planned to keep the source code of their models private citing concerns about malicious applications. After OpenAI faced public backlash, however, it released the source code for GPT-2 to GitHub three months after its release. OpenAI did not publicly release the source code or pretrained weights for the GPT-3 model. At the time of GPT-3's release, GPT-2 was still the most powerful open source language model in the world. 2022 also saw the rise of larger and more powerful models under licenses of varying openness including Meta's OPT. The Open Source Initiative consulted experts over two years to create a definition of "open-source" that would fit the needs of AI software and models. The most controversial aspect relates to data access, since some models are trained on sensitive data which can't be released. In 2024, they published the Open Source AI Definition 1.0 (OSAID 1.0). It requires full release of the software for processing the data, training the model and making inferences from the model. For the data, it only requires access to details about the data used to train the AI so others can understand and re-create it. On August 22, 2022, open-source text-to-image model Stable Diffusion was first released. In 2023, Meta's weights-available Llama 1 and 2, and Mistral AI's open-weight Mistral and Mixtral models were first released, along with MosaicML's smaller open-source models. The release of the Llama models was a milestone in generating interest in open-weight and open-source models.
== Measurement == An SaO2 (arterial oxygen saturation, as determined by an arterial blood gas test) value below 90% indicates hypoxemia (which can also be caused by anemia). Hypoxemia due to low SaO2 is indicated by cyanosis. Oxygen saturation can be measured in different tissues:
=== Stress and anxiety === In vitro studies examining the effects of CRH1 antagonists on the hypothalamic–pituitary–adrenal axis showed that antalarmin inhibited ACTH release in rat anterior pituitary cells, as well as inhibited cortisol synthesis and release in human adrenal cells. In vivo studies revealed that pre-treating rats with antalarmin inhibited increases in plasma ACTH following CRH injection (i.v.), with no effect on baseline levels. However, another study demonstrated that 8 weeks of antalarmin administered twice daily (i.p.) in rats significantly lowered basal ACTH and corticosterone levels, resulting in reduced adrenocortical responsiveness to ACTH. When antalarmin was administered to primates, it also inhibited increases in plasma ACTH, as well as prevented the anxiety response produced by a social stressor (e.g. presentation of another male in an unfamiliar environment). With regards to neurochemical effects, antalarmin has been shown to inhibit increases in extracellular cortical norepinephrine induced by rat tail pinch, suggesting that CHR1 receptors may be implicated in stress-evoked norepinephrine release in the cortex. Antalarmin was also shown to have electrophysiological effects by partially reversing the inhibition of neuronal firing in the dorsal raphe nucleus that occurs following intracerebroventricular (i.c.v) administration of CRH. Studies using CRH receptor antagonists such as antalarmin in anxiety models have shown that these agents produce effects similar to clinically effective anxiolytics.
== Businesses == Golden Harvest Agro Industries Limited Golden Harvest InfoTech Limited Golden Harvest Ice-Cream Limited (Bloop) Golden Harvest Foods Limited Golden Harvest Express Golden Harvest Dairy Limited Fatehpur Estate Limited Golden Harvest Developers Limited Golden Harvest Commodities Limited Nippon Express Bangladesh Limited, a joint venture with Nippon Express. Jubilant Golden Harvest Limited, a joint venture with Jubilant FoodWorks. Cold Chain Bangladesh Limited, a joint venture with International Finance Corporation.
Unlike amphetamine abuse, where drug tolerance necessitates escalating doses to achieve the same effect, tolerance to clinically relevant doses of amphetamine plateaus after the initial titration period, and "drug holidays" (i.e., temporary treatment discontinuation) are not required to prevent the development of tolerance. A 2026 systematic review on ADHD medication tolerance found evidence of tolerance developing to some affective state effects of amphetamine (e.g., positive mood and drug liking) within two weeks of daily use, but little to no evidence of long-term tolerance to its therapeutic or cardiovascular effects.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue natural peptide, while TB-500 is a commercial label applied to a short synthetic fragment of it. The two differ in length, sequence coverage and how they are handled in the laboratory.
Published work usually examines actin binding, cell migration and tissue repair endpoints in cell and animal models. Findings are generally described as preliminary, and controlled human data remain limited.
Because TB-500 is a trade name rather than a chemical identifier, different vendors and papers may attach it to different fragment lengths. Checking the stated sequence is the practical way to resolve the ambiguity.
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.